期刊文献+

靶向性基因治疗载体 被引量:1

Targeted vectors of gene therapy
下载PDF
导出
摘要 有效并且安全的靶向性载体是基因治疗能否成功的关键。本文简要介绍了基因治疗靶向性载体的作用原理和选择原则;比较了几种常用的病毒载体、非病毒载体以及新开发的载体系统的优缺点。 Effective and secure targeted vector is the key of the gene therapy succeed or not. In this paper, the action principle and selection principle of the gene therapy vectors are briefly introduced and the advantage and disadvantage of some usual viral vectors, non -viral vectors and the latest developed deliver systems are compared.
出处 《大连医科大学学报》 CAS 2007年第4期400-403,共4页 Journal of Dalian Medical University
关键词 基因治疗 靶向性载体 安全性 有效性 gene therapy targeted vector security validity
  • 相关文献

参考文献14

  • 1Barenholz Y.Liposome application:problems and prospeets[J].Curt Opin Colloid Interface Sci,2001,6 (1):66-77.
  • 2黄世文,卓仁禧.高分子基因传递载体研究进展[J].科学通报,2003,48(5):405-409. 被引量:11
  • 3Andrew D,Miller.Cationic Liposomes for Gene Therapy[J].Angew Chem Int Ed,1998,37:68-1785.
  • 4晏霆,朱满洲.基因治疗与基因载体[J].安徽医药,2002,6(4):72-73. 被引量:7
  • 5石靖,齐宪荣,杨莉,费然,魏来.大豆糖苷修饰阳离子脂质体的体外肝细胞靶向性[J].药学学报,2006,41(1):19-23. 被引量:6
  • 6Musgrave DS,Pruchnic R,Bosch P,et al.Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic ptoterin-2[J].J bone Joint Surg Br,2002,84:120-127.
  • 7Pandori M,Hobson D,Sano T.Andenovirus-microbead conjugates possess enhanced infectivity:a new strategy for localized gene delivery[J].Virology,2002,299:204 -212.
  • 8Nasz I,Adam E.Recombinant adenovirns vectors for gene therapy and clinical trials[J].Acta Microbiol Immunol Hung,2001,48:323-348.
  • 9Adam E,Naaz I.Adenovirus vectors and their clinical application in gene therapy[J].Orr Hetil,2001,142:2061-2070.
  • 10Boletta A,Benigni A,Lutz J,et al.Nonviral gene delivery to therat kidney with polyethyl -enimine[J].Human Gene Ther,1997,8:1243.

二级参考文献131

  • 1严文伟,齐宪荣,魏来,费然,丛旭,王宇.阳离子脂质材料和聚乙二醇对脂质体细胞转染率及膜流动性的影响[J].药学学报,2003,38(9):698-701. 被引量:2
  • 2石靖,严文伟,齐宪荣,杨莉,张鹂.豆甾醇糖苷/聚乙二醇衍生物修饰的阳性脂质体体内分布和肝实质细胞靶向性[J].药学学报,2004,39(7):551-555. 被引量:6
  • 3[1]Culver K W. Gene Therapy: A Primer for Physician. Larchmont: Mary Ann Liebert,Inc, 1996
  • 4[2]Mahato R I, Smith L C, Rolland A. Pharmaceutical perspective of nonviral gene therapy. Adv Genet, 1999, 41: 95~156
  • 5[3]Lehrman S. Virus treatment questioned after gene therapy death. Nature, 1999, 401: 517~518
  • 6[4]Mashall E. Gene therapy death promotes review of adenovirus vectors. Science, 1999, 286: 2244~2245
  • 7[5]Anderson W F. Human gene therapy. Nature, 1998, 392(Supp): 25~30
  • 8[6]Rolland A P, Mumper R J. Plasmid delivery to muscle: Recent advances in polymer delivery systems. Adv Drug Deliv Rev, 1998, 30(1~3): 151~172
  • 9[7]Lee R J, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther DrugCarrier Syst, 1997, 14(2): 173~206
  • 10[8]Luo D, Saltzman M. Synthetic DNA delivery systems. Nat Biotech, 2000,18: 33~37

共引文献30

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部